Brain Activity Associated With Inhibition of Action in Attention-deficit

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-17

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Inhibitory control allows individuals to suppress unwanted actions and to resist irrelevant stimuli. It is thought to be a core deficit in Attention-deficit/hyperactivity disorder (ADHD). The present study aims at evaluating this deficit in adults with ADHD. Executive and inhibitory capacities, as well as the neural mechanisms underlying inhibitory control, will be assessed in adults with ADHD and two control groups of participants.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Brain Activity in Adults With ADHD During Neuropsychological Tasks

NCT02578342

Attention Deficit Hyperactivity Disorder (ADHD)

COMPLETED

Neural Mechanisms of Attention Lapses in Adult ADHD

NCT03948607

Attention Deficit Disorder Hyperactivity Disorder

COMPLETED

Behavior in Children With Attention Deficit Hyperactivity Disorder and in Healthy Volunteers

NCT00026546

Attention Deficit Hyperactivity Disorder

COMPLETED

Identification of Biomarkers of Attention Deficit Disorder With or Without Hyperactivity (ADHD) by a Metabolomic Approach in Children

NCT03436017

Adhd

COMPLETED

Oculometry as an Attentional Mechanism Evaluation Tool and Attention Deficit Hyperactivity Inhibition

NCT03546010

Attention Deficit-Hyperactivity

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

ADHD is a psychiatric disorder characterized by symptoms of inattention, hyperactivity, and impulsivity (DSM-V, 2013). An impairment of inhibitory control has been suggested as the primary deficit in children with ADHD, which is thought to cause secondary impairments in executive functioning. A few studies investigated executive capacities in adults with ADHD. Specifically, an impairment in action inhibition has been reported in ADHD participants. Moreover, inhibition of action is often associated with distinctive electroencephalographic (EEG) correlates. The present study aim at combining both novel inhibitory control measurement techniques and EEG analysis in temporal and frequency domains to assess the sensitivity and the specificity of an inhibitory deficit in adults with ADHD. This is part of an improvement in the procedures for diagnosing ADHD syndrome and its functional evaluation.

The study will analyze the EEG activity associated with two stop-signal tasks requiring inhibitory capacities. A set of other cognitive skills will also be evaluated during a neuropsychological assessment. The results of ADHD patients will be compared with those of a control group (healthy volunteers) to assess the sensitivity of an inhibition deficit to the disorder. These same results will also be compared with those of a second control group (patients with a negative diagnosis of ADHD) to assess the specificity of the inhibitory deficit.

This experimental strategy results in the involvement of three groups of participants (ADHD patients and two control groups) in three visits (neuropsychological assessment and two EEG sessions).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Attention Deficit Hyperactivity Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

This study is pathophysiological, monocentric, comparative, and controlled with 3 groups compared: ADHD patients, control patients (negative diagnosis of ADHD), and healthy volunteers.

The three groups will complete the same protocol, in the same manner.

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ADHD group

ADHD group: 20 participants having received a positive diagnosis of ADHD

Group Type EXPERIMENTAL

EEG experimental sessions 1

Intervention Type OTHER

An EEG experimentation session on the stop-signal task of inhibiting a prepared discrete graphic action.

EEG experimental sessions 2

Intervention Type OTHER

An EEG experimentation session on the stop-signal task of inhibiting an ongoing rhythmic action

Control group 1

Control group 1: 20 participants having received a negative diagnosis of ADHD

Group Type OTHER

EEG experimental sessions 1

Intervention Type OTHER

An EEG experimentation session on the stop-signal task of inhibiting a prepared discrete graphic action.

EEG experimental sessions 2

Intervention Type OTHER

An EEG experimentation session on the stop-signal task of inhibiting an ongoing rhythmic action

Control group 2

Control group 2: 20 participants as healthy volunteers

Group Type OTHER

EEG experimental sessions 1

Intervention Type OTHER

An EEG experimentation session on the stop-signal task of inhibiting a prepared discrete graphic action.

EEG experimental sessions 2

Intervention Type OTHER

An EEG experimentation session on the stop-signal task of inhibiting an ongoing rhythmic action

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EEG experimental sessions 1

An EEG experimentation session on the stop-signal task of inhibiting a prepared discrete graphic action.

Intervention Type OTHER

EEG experimental sessions 2

An EEG experimentation session on the stop-signal task of inhibiting an ongoing rhythmic action

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 18 and 50,

* Visual, auditory (authorized apparatus), motor skills suitable for the proper realization of neuropsychological tests,
* Being right-handed,
* Free, informed and written consent signed by the participant and the investigator
* Person affiliated or beneficiary of a social security scheme.
* For the ADHD group:

* Diagnosis of ADHD according to DSM-V criteria (APA, 2013),

For the patient control group:

• Patient who consulted for a cognitive complaint and for whom the diagnosis of ADHD was rejected according to the criteria of DSM-V (APA, 2013).

Exclusion Criteria

* General or progressive neurological disease resulting in cognitive impairment (multiple sclerosis, Parkinson's disease, stroke, etc.),
* Insufficient linguistic level in French to participate in neuropsychological assessment,
* Patient placed under judicial protection or under another protective regime,
* Severe depression according to DSM-V criteria (APA, 2013),
* Autism spectrum disorder, developmental coordination disorder.

-For the healthy voluntary control group:
* Presence of a cognitive complaint or pathology which may impair his cognitive functions

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes